{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:24:29Z","timestamp":1773235469245,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"crossref","award":["NS056181"],"award-info":[{"award-number":["NS056181"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.expneurol.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T18:40:13Z","timestamp":1329244813000},"page":"273-281","source":"Crossref","is-referenced-by-count":10,"title":["Susceptibility to a parkinsonian toxin varies during primate development"],"prefix":"10.1016","volume":"235","author":[{"given":"B.A.","family":"Morrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"D.E.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Diano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Elsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.02.005_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0300-483X(99)00198-5","article-title":"Toxicologic evidence of developmental neurotoxicity of environmental chemicals","volume":"144","author":"Andersen","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1523\/JNEUROSCI.4269-04.2005","article-title":"Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease","volume":"25","author":"Andrews","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0006-8993(78)90049-5","article-title":"Regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment","volume":"157","author":"Bacopoulos","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.reprotox.2007.01.007","article-title":"The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder","volume":"23","author":"Barlow","year":"2007","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0025","first-page":"83","article-title":"Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat","volume":"14","author":"Bayer","year":"1993","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0030","series-title":"Neurodevelopment, Aging and Cognition","first-page":"18","article-title":"Prenatal monoaminergic innervation of the cerebral cortex: differences between rodents and primates","author":"Berger","year":"1992"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0040","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","article-title":"A tale on animal models of Parkinson's disease","volume":"26","author":"Bezard","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12031-008-9128-9","article-title":"Selection of reference genes for quantitative real-time RT-PCR studies in mouse brain","volume":"37","author":"Boda","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-8993(87)90602-0","article-title":"Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP","volume":"419","author":"Brooks","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia","volume":"93","author":"Brown","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00441-004-0908-4","article-title":"Ontogenic cell death in the nigrostriatal system","volume":"318","author":"Burke","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0065","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0070","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Mov. Disord."},{"issue":"322","key":"10.1016\/j.expneurol.2012.02.005_bb0075","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(83)90802-4","article-title":"Aetiology of Parkinson's disease","volume":"ii","author":"Calne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3727\/000000006783981990","article-title":"Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis","volume":"15","author":"Carvey","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0085","first-page":"548","article-title":"Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey","volume":"20","author":"Chiueh","year":"1984","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cne.10261","article-title":"Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra","volume":"450","author":"Chu","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(01)00171-3","article-title":"Translating developmental time across mammalian species","volume":"105","author":"Clancy","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrn3039","article-title":"Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates","volume":"12","author":"Collier","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35046114","article-title":"Coenzyme Q is an obligatory cofactor for uncoupling protein function","volume":"408","author":"Echtay","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0410","doi-asserted-by":"crossref","unstructured":"Ek, C.J., Dziegielewska, K.M., Habgood, M.D., Saunders, N.R., in press. Barriers in the developing brain and Neurotoxicology. Neurotoxicology. doi.org\/10.1016\/j.neuro.2011.12.009.","DOI":"10.1016\/j.neuro.2011.12.009"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0135","series-title":"Encylopedia of Neuoscience","first-page":"539","article-title":"Dopamine","author":"Elsworth","year":"2009"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0024-3205(87)90359-6","article-title":"Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum","volume":"40","author":"Elsworth","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(99)00437-6","article-title":"Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment","volume":"95","author":"Elsworth","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00294662","article-title":"Transplacental effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on brain dopaminergic neurons in the mouse. An immunohistochemical study","volume":"79","author":"Furune","year":"1989","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0145","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1471-4159.1998.70051973.x","article-title":"Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice","volume":"70","author":"Gainetdinov","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2011.03.005","article-title":"Gene-environment interactions: key to unraveling the mystery of Parkinson's disease","volume":"94","author":"Gao","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?","volume":"24","author":"German","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0022-3565(25)24767-X","article-title":"Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice","volume":"257","author":"Giovanni","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-3565(25)22503-4","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: systemic administration","volume":"270","author":"Giovanni","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0170","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-3565(25)22504-6","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: central administration of 1-methyl-4-phenylpyridinium","volume":"270","author":"Giovanni","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-3782(01)00189-X","article-title":"Neurotransmitters and neuromodulators during early human development","volume":"65","author":"Herlenius","year":"2001","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/clpt.2010.138","article-title":"Gene-environment interactions in Parkinson's disease: the importance of animal modeling","volume":"88","author":"Horowitz","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0185","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1210\/en.2003-0163","article-title":"Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease","volume":"144","author":"Horvath","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0190","series-title":"Unbiased stereology: three dimensional measurement in microscopy","author":"Howard","year":"1998"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0028-3908(85)90068-1","article-title":"Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)","volume":"24","author":"Jarvis","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0024-3205(85)90062-1","article-title":"Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects","volume":"36","author":"Johannessen","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0387-7604(95)00079-Q","article-title":"Neurotransmitters and vulnerability of the developing brain","volume":"17","author":"Johnston","year":"1995","journal-title":"Brain Dev."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0773.1989.tb00654.x","article-title":"MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species","volume":"64","author":"Jossan","year":"1989","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0215","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1471-4159.1992.tb09766.x","article-title":"Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease","volume":"58","author":"Kish","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0220","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(84)90293-3","article-title":"1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra","volume":"48","author":"Langston","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-3806(82)90095-5","article-title":"The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey","volume":"256","author":"Levitt","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0230","series-title":"The Primate Nervous System","first-page":"263","article-title":"Dopamine systems in the primate brain","author":"Lewis","year":"1997"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuroscience.2005.09.035","article-title":"Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"137","author":"Lloyd","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0240","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.1990.tb03156.x","article-title":"Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"55","author":"Melamed","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mrgentox.2008.09.013","article-title":"Environmental-induced oxidative stress in neurodegenerative disorders and aging","volume":"674","author":"Migliore","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0250","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2818.1990.tb03019.x","article-title":"Efficient estimation of cell volume and number using the nucleator and the disector","volume":"159","author":"Moller","year":"1990","journal-title":"J. Microsc."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0260","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cne.20599","article-title":"Development of A9\/A10 dopamine neurons during the second and third trimesters in the African green monkey","volume":"488","author":"Morrow","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0265","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.expneurol.2007.01.009","article-title":"Apoptotic natural cell death in developing primate dopamine midbrain neurons occurs during a restricted period in the second trimester of gestation","volume":"204","author":"Morrow","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2011.05.046","article-title":"Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease","volume":"189","author":"Morrow","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0275","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0003-2697(87)90431-3","article-title":"A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatography","volume":"162","author":"Naoi","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0024-3205(91)90348-F","article-title":"Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in prenatal stage on the dopamine system in the postnatal mouse brain","volume":"48","author":"Ochi","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-3806(96)00173-3","article-title":"The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra","volume":"98","author":"Oo","year":"1997","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0014-4886(95)90012-8","article-title":"Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain","volume":"131","author":"Perez-Otano","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(93)90800-W","article-title":"Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets","volume":"230","author":"Rose","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/978-0-387-76715-4_8","article-title":"Neurotransmitters and the development of neuronal circuits","volume":"621","author":"Ruediger","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0892-0362(94)90049-3","article-title":"Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"16","author":"Russo","year":"1994","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1006991809927","article-title":"Barriers in the immature brain","volume":"20","author":"Saunders","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0315","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0021-9673(01)96513-6","article-title":"Cation-exchange high-performance liquid chromatography assay for the nigrostriatal toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B generated metabolites in brain tissues","volume":"398","author":"Shinka","year":"1987","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0325","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"269","article-title":"Development of mesencephalic dopamine neurons in the nonhuman primate relationship to survival and growth","author":"Sladek","year":"1995"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0330","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ana.10543","article-title":"Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death","volume":"53","author":"Sullivan","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0335","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0340","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","article-title":"VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity","volume":"94","author":"Takahashi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0345","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3940(87)90261-8","article-title":"Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine","volume":"73","author":"Takamidoh","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2012.02.005_bb0350","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/mds.22721","article-title":"Advances in environmental epidemiology","volume":"25","author":"Tanner","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10803-008-0624-0","article-title":"Pleiotropic effects of neurotransmission during development: modulators of modularity","volume":"39","author":"Thompson","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/neur.1996.0019","article-title":"Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice","volume":"5","author":"Vaglini","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1008656928861","article-title":"Mechanisms of drug transfer across the human placenta","volume":"20","author":"van der Aa","year":"1998","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0370","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/REVNEURO.2003.14.3.217","article-title":"The role of neurotransmitters in neurite outgrowth and synapse formation","volume":"14","author":"van Kesteren","year":"2003","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0375","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuro.2010.04.007","article-title":"Gene-environment interactions in Parkinson's disease and other forms of parkinsonism","volume":"31","author":"Vance","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0380","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1073858408319974","article-title":"Etiopathogenesis of Parkinson disease: a new beginning?","volume":"15","author":"Weidong","year":"2009","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0385","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfn263","article-title":"Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer","volume":"108","author":"Wells","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0390","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cercor\/8.4.321","article-title":"Widespread origin of the primate mesofrontal dopamine system","volume":"8","author":"Williams","year":"1998","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2012.02.005_bb0395","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdrb.10037","article-title":"Species comparison of postnatal CNS development: functional measures","volume":"68","author":"Wood","year":"2003","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1427.023","article-title":"Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance","volume":"1147","author":"Zhou","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2012.02.005_bb0405","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03159728","article-title":"Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism","volume":"10","author":"Zigmond","year":"1989","journal-title":"Mol. Chem. Neuropathol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T20:01:57Z","timestamp":1742500917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488612000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0014488612000647"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.02.005","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}